Global hemostasis in pregnancy: Are we using thromboelastography to its full potential?

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 7, 2010, Pages 738-746

  Othman, Maha ^a,b   Falcón, Bani J ^b   Kadir, Rezan ^c  

^a LAURENTIAN UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

amniotic fluid; global hemostasis; placenta; Pregnancy complications; thromboelastography

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM;

AMNION FLUID; ANESTHESIA; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CELL INTERACTION; CLINICAL PRACTICE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; GESTATIONAL AGE; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; PARTIAL THROMBOPLASTIN TIME; PLACENTA; POINT OF CARE TESTING; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; STANDARDIZATION; THROMBOCYTE; THROMBOELASTOGRAPHY;

BLOOD COAGULATION TESTS; FEMALE; HEMOSTASIS; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBELASTOGRAPHY;

EID: 78049243606     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1265290     Document Type: Review

References (93)

1. Holmes V A. Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis? Proc Nutr Soc 2003 62 (2) 479-493
2. Higgins J R., Papayianni A, Brady H R., Darling M R., Walshe J J. Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. Am J Obstet Gynecol 1998 179 (2) 464-469
3. Sheppard B L., Bonnar J. The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation. Br J Obstet Gynaecol 1976 83 (12) 948-959
4. Lanir N, Aharon A, Brenner B. Haemostatic mechanisms in human placenta. Best Pract Res Clin Haematol 2003 16 (2) 183-195
5. Lanir N, Aharon A, Brenner B. Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Hemost 2003 29 (2) 175-184
6. Kuczyski J, Uszyski W, Zekanowska E, Soszka T, Uszyski M. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium. Eur J Obstet Gynecol Reprod Biol 2002 105 (1) 15-19
7. Clark P, Greer I A. Prevention and treatment of arterial thrombosis in pregnancy. Semin Thromb Hemost 2003 29 (2) 155-164
8. Higgins J R., Walshe J J., Darling M R., Norris L, Bonnar J. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol 1998 179 (2) 520-526
9. Astedt B, Lindoff C, Lecander I. Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy. Semin Thromb Hemost 1998 24 (5) 431-435
10. Lockwood C J., Bach R, Guha A, Zhou X D., Miller W A., Nemerson Y. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 1991 165 (5 Pt 1) 1335-1341
11. Weiner A E., Reid D E., Roby C C. The hemostatic activity of amniotic fluid. Science 1949 110 (2851) 190-191
12. Erez O, Gotsch F, Mazaki-Tovi S et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med 2009 22 (8) 672-687
13. Uszyski M, Zekanowska E, Uszyski W, Kuczyski J. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 2001 95 (2) 163-166
14. Glinoer D, De Nayer P, Robyn C, Lejeune B, Kinthaert J, Meuris S. Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 1993 16 (11) 881-888
15. Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004 114 (56) 409-414
16. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003 29 (2) 125-130
17. Stirling Y, Woolf L, North W R., Seghatchian M J., Meade T W. Haemostasis in normal pregnancy. Thromb Haemost 1984 52 (2) 176-182
18. Clark P, Brennand J, Conkie J A., McCall F, Greer I A., Walker I D. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998 79 (6) 1166-1170
19. Bonnar J. Hemostatic function and coagulopathy during pregnancy. Obstet Gynecol Annu 1978 7 195-217
20. Coopland A AN, Alkjaersig N, Fletcher A P. Reduction in plasma factor 13 (fibrin stabilizing factor) concentration during pregnancy. J Lab Clin Med 1969 73 (1) 144-153
21. Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997 73 (1) 31-36
22. Schlit A F., Col-De Beys C, Moriau M, Lavenne-Pardonge E. Acquired activated protein C resistance in pregnancy. Thromb Res 1996 84 (3) 203-206
23. Woodhams B J., Candotti G, Shaw R, Kernoff P B. Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion. Thromb Res 1989 55 (1) 99-107
24. Bellart J, Gilabert R, Miralles R M., Monasterio J, Cabero L. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gynecol Obstet Invest 1998 46 (1) 17-21
25. O'Brien W F., Saba H I., Knuppel R A., Scerbo J C., Cohen G R. Alterations in platelet concentration and aggregation in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1986 155 (3) 486-490
26. Holthe M R., Staff A C., Berge L N., Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol 2004 190 (4) 1128-1134
27. Bremme K, Ostlund E, Almqvist I, Heinonen K, Blombäck M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992 80 (1) 132-137
28. Kjellberg U, Andersson N E., Rosén S, Tengborn L, Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999 81 (4) 527-531
29. Walker M C., Garner P R., Keely E J., Rock G A., Reis M D. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997 177 (1) 162-169
30. Aharon A, Brenner B, Katz T, Miyagi Y, Lanir N. Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Thromb Haemost 2004 92 (4) 776-786
31. Beller F K., Ebert C. The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium. Eur J Obstet Gynecol Reprod Biol 1982 13 (3) 177-197
32. Holmes V A., Wallace J M., Gilmore W S., McFaul P, Alexander H D. Tissue factor expression on monocyte subpopulations during normal pregnancy. Thromb Haemost 2002 87 (6) 953-958
33. Holmes V A., Wallace J M., Gilmore W S., McFaul P, Alexander H D. Plasma levels of the immunomodulatory cytokine interleukin-10 during normal human pregnancy: a longitudinal study. Cytokine 2003 21 (6) 265-269
34. Cadroy Y, Grandjean H, Pichon J et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993 100 (5) 416-420
35. van Wersch J W., Ubachs J M. Blood coagulation and fibrinolysis during normal pregnancy. Eur J Clin Chem Clin Biochem 1991 29 (1) 45-50
36. Biezenski J J., Moore H C. Fibrinolysis in normal pregnancy. J Clin Pathol 1958 11 (4) 306-310
37. Kruithof E K., Tran-Thang C, Gudinchet A et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987 69 (2) 460-466
38. Wright J G., Cooper P, Astedt B et al. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time. Br J Haematol 1988 69 (2) 253-258
39. Francalanci I, Comeglio P, Liotta A A. et al. D-dimer concentrations during normal pregnancy, as measured by ELISA. Thromb Res 1995 78 (5) 399-405
40. Rosenkranz A, Hiden M, Leschnik B et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 2008 99 (2) 331-337
41. Hastwell G B. Accelerated clotting time: an amniotic fluid thromboplastic activity index of fetal maturity. Am J Obstet Gynecol 1978 131 (6) 650-654
42. Liu E H., Shailaja S, Koh S C., Lee T L. An assessment of the effects on coagulation of midtrimester and final-trimester amniotic fluid on whole blood by thrombelastograph analysis. Anesth Analg 2000 90 (2) 333-336
43. Maybury H J., Waugh J JS, Gornall A, Pavord S. There is a return to non-pregnant coagulation parameters after four not six weeks postpartum following spontaneous vaginal delivery. Obstet Med 2008 1 92-94
44. Maybury H JGA, Kurinczuk J J., Konje J C., Pavord S. Use of thromboelastography to assess haemostatic function in postpartum women. Br J Obstet Gynaecol 2003 110 960-961
45. Gorton H, Lyons G. Is it time to invest in a thromboelastograph? Int J Obstet Anesth 1999 8 (3) 171-178
46. Wegner J P., Popovsky M A. Clinical utility of thromboelastography: one size does not fit all. Semin Thromb Hemost 2010 36 (7) 699-706
47. Chitlur M L., Lusher J. Standardization of thromboelastography: values and challenges. Semin Thromb Hemost 2010 36 (7) 707-711
48. MacDonald S, Luddington R. Critical factors contributing to the thromboelastography trace. Semin Thromb Hemost 2010 36 (7) 712-722
49. Sharma S K., Philip J, Wiley J. Thromboelastographic changes in healthy parturients and postpartum women. Anesth Analg 1997 85 (1) 94-98
50. Steer P L., Krantz H B. Thromboelastography and Sonoclot analysis in the healthy parturient. J Clin Anesth 1993 5 (5) 419-424
51. Sharma S, Wallace D, Sidawi E, Lacour T, Yamanouchi K, Padakandla B. Thromboelastography with disposable cups and pins: normal measurements in non-pregnant, pregnant, and postpartum women. Anesth Analg 1995 80 S432
52. James A H., Tapson V F., Goldhaber S Z. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005 193 (1) 216-219
53. Grogan H, Gorton H. Thromboelastography (TEG) changes during pregnancy: a personal view. Presented at: The Obstetric Anaesthetists' Association annual meeting May 9-10, 2002 Nottingham, United Kingdom
54. Erez O, Romero R, Vaisbuch E et al. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor. J Matern Fetal Neonatal Med 2010 23 (1) 23-33
55. Erez O, Romer R, Vaisbuch E et al. Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation. J Matern Fetal Neonatal Med 2009 22 (11) 971-982
56. Rai R, Tuddenham E, Backos M et al. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod 2003 18 (12) 2540-2543
57. Hayashi M, Numaguchi M, Ohkubo N, Yaoi Y. Blood macrophage colony-stimulating factor and thrombin-antithrombin III complex concentrations in pregnancy and preeclampsia. Am J Med Sci 1998 315 (4) 251-257
58. Hayashi M, Inoue T, Hoshimoto K, Negishi H, Ohkura T, Inaba N. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. Eur J Haematol 2002 69 (56) 297-302
59. Chaiworapongsa T, Yoshimatsu J, Espinoza J et al. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med 2002 11 (6) 362-367
60. Rosen T, Kuczynski E, O'Neill L M., Funai E F., Lockwood C J. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001 10 (5) 297-300
61. Steer P L., Finley B E., Blumenthal L A. Abruptio placentae and disseminated intravascular coagulation: use of thrombelastography and Sonoclot analysis. Int J Obstet Anesth 1994 3 (4) 229-233
62. Fries D, Innerhofer P, Klingler A et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 2002 94 (5) 1280-1287
63. Lowenwirt I, Dadic P, Krishnamurthy V. Essential thrombocythemia and epidural analgesia in the parturient. Does thromboelastography help? Reg Anesth 1996 21 (6) 525-528
64. Orlikowski C E., Payne A J., Moodley J, Rocke D A. Thrombelastography after aspirin ingestion in pregnant and non-pregnant subjects. Br J Anaesth 1992 69 (2) 159-161
65. Orlikowski C E., Moodley J, Rocke D A. Thrombelastography in pregnant patients on low-dose aspirin. Lancet 1991 338 (8777) 1276-1277
66. Sharma S K., Philip J, Whitten C W., Padakandla U B., Landers D F. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology 1999 90 (2) 385-390
67. Sharma S, Wallace D, Sidawi E, Whitten C, Davenport M, Gambling D. Thromboelastography: assessment of coagulation abnormalities in preeclamptic patients. Anesth Analg 1995 80 S433
68. Hawthorne L LG, Columb M. Thromboelastography and preeclampsia. Br J Anaesth 1996 76 A320
69. Orlikowski C E., Rocke D A., Murray W B. et al. Thrombelastography changes in pre-eclampsia and eclampsia. Br J Anaesth 1996 77 (2) 157-161
70. Landers D F., Newland M, Penney L L. Multiple uterine rupture and crushing injury of the fetal skull after blunt maternal trauma. A case report. J Reprod Med 1989 34 (12) 988-993
71. Huissoud C, Carrabin N, Audibert F et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009 116 (8) 1097-1102
72. Moopanar D, Naidu S, Moodley J, Gouws E. Thromboelastography in abruptio placentae. J Obstet Gynaecol 1997 17 (3) 229-233
73. Sharma S K., Vera R L., Stegall W C., Whitten C W. Management of a postpartum coagulopathy using thrombelastography. J Clin Anesth 1997 9 (3) 243-247
74. Whitta R KSCD, Cox D J., Mallett S V. Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 1995 74 (4) 464-468
75. Hendrickx P, Van de Velde M, Vandermeersch E, Spitz B, Van Assche A. Thromboelastography (TEG) in severe pre-eclampsia complicated with the HELLP syndrome. Eur J Anesth 2001 18 109
76. Gorton H, Lyons G. Thromboelastography (TEG) and low molecular weight heparin therapy in pregnancy. Anesthesiology 1999 90 A36 [Society for Obstetric Anesthesia and Perinatology Supplement]
77. Harnett M JP, Bhavani Shankkar K, Datta S. Thromboelastography in parturients receiving magnesium. Anesthesiology 2000 92 A52 [Society for Obstetric Anesthesia and Perinatology Supplement]
78. Kang Y G., Martin D J., Marquez J et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985 64 (9) 888-896
79. Shore-Lesserson L, Manspeizer H E., DePerio M, Francis S, Vela-Cantos F, Ergin M A. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999 88 (2) 312-319
80. Mallett S V., Platt M. Role of thrombelastography in bleeding diatheses and regional anaesthesia. Lancet 1991 338 (8769) 765-766
81. Mahla E, Lang T, Vicenzi M N. et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesth Analg 2001 92 (3) 572-577
82. Samama C M. Thromboelastography: the next step. Anesth Analg 2001 92 (3) 563-564
83. Whitten C W., Greilich P E. Thromboelastography: past, present, and future. Anesthesiology 2000 92 (5) 1223-1225
84. Watson H G. Thromboelastography should be available in every labour ward. Int J Obstet Anesth 2005 14 (4) 325-327
85. Kitchen D P., Kitchen S, Jennings I, Woods T, Walker I. Quality assurance and quality control of thrombelastography and rotational thromboelastometry: The UK NEQAS for Blood Coagulation experience. Semin Thromb Hemost 2010 36 (7) 757-763
86. Lefkowitz J B., Clarke S H., Barbour L A. Comparison of protein S functional and antigenic assays in normal pregnancy. Am J Obstet Gynecol 1996 175 (3 Pt 1) 657-660
87. Bern M M. Acquired and congenital defects encountered during pregnancy and in the fetus In: Bern MM, Frigoletto FD Hematologic Disorders in Maternal-Fetal Medicine. New York, NY Wiley-Liss 1990 395
88. Letsky E A. Coagulation Problems during Pregnancy. Edinburgh, United Kingdom Churchill Livingstone 1985
89. McKillop C, Forbes C D., Howie P W., Prentice C M. Soluble fibrinogen/fibrin complexes in pre-eclampsia. Lancet 1976 1 (7950) 56-58
90. Comeglio P, Fedi S, Liotta A A. et al. Blood clotting activation during normal pregnancy. Thromb Res 1996 84 (3) 199-202
91. Uchikova E H., Ledjev I I. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2005 119 (2) 185-188
92. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994 101 (6) 488-492
93. Ishii A, Yamada S, Yamada R, Hamada H. t-PA activity in peripheral blood obtained from pregnant women. J Perinat Med 1994 22 (2) 113-117